Weiqin Yang
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Towards biomarker-driven cancer immunotherapy: the rising of a protein phosphatase regulator.
Journal: Signal transduction and targeted therapy
Published: July 31, 2025
Myeloid-intrinsic cell cycle-related kinase drives immunosuppression to promote tumorigenesis.
Journal: iScience
Published: January 18, 2023
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties.
Journal: Journal of medicinal chemistry
Published: November 30, 2022
The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma.
Journal: Cancer letters
Published: July 29, 2022
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver.
Journal: Cellular & molecular immunology
Published: December 28, 2021
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis.
Journal: Cancer letters
Published: July 21, 2021
Study on the Mechanism of Olfactomedin 4-shRNA Plasmid Chitosan Magnetic Nanoparticles in Intestinal Metaplasia of Chronic Atrophic Gastritis.
Journal: Journal of nanoscience and nanotechnology
Published: July 27, 2020
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.
Journal: Cellular & molecular immunology
Published: April 24, 2020
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma.
Journal: Science translational medicine
Published: October 04, 2019
miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Journal: Cell death & disease
Published: June 20, 2017
Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Journal: The Journal of pathology
Published: October 22, 2015
Last Updated: 09/26/2026